Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Comment by stockman6on Nov 01, 2002 7:31pm
233 Views
Post# 5552473

Newto........

Newto........I still come to be amused now and again also, however after awhile it becomes very, VERY, boring............there are definately better places to spend your time, if you have any kind of life. The most amunsing thing is that after tens of thousands of posts by hundreds of posters, the story for ISA, in a nutshell, remains the same: the stock will directionally do really well if the clinical trial results are positive, and directionally really lousy if the results aren't. Regardless of the market sentiment. Regardless of whether or not ISA talks about clinical trial results when announcing that they were issued patents (TEEVEE-LOL). Regardless of whether or not PEY granted options at a discount. Regardless of candles, RSI, or MACD. etc, etc, etc. So, my suggestion only, view ISA for what it is, a speculative play with big potential upside, treat it as such, and get some fresh air.
Bullboard Posts